Entourage Health Corp. (ENTG.V)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 178.68 Million CAD | 20.98% |
| 2022 | 147.7 Million CAD | 20.28% |
| 2021 | 122.79 Million CAD | 26.28% |
| 2020 | 97.23 Million CAD | 31.87% |
| 2019 | 73.73 Million CAD | 571.8% |
| 2018 | 10.97 Million CAD | -24.16% |
| 2017 | 14.47 Million CAD | 62636.31% |
| 2016 | 23.06 Thousand CAD | 79.47% |
| 2015 | 12.85 Thousand CAD | 28.55% |
| 2014 | 9999.00 CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 184.17 Million CAD | 3.07% |
| 2024 Q2 | 187.8 Million CAD | 1.97% |
| 2023 Q4 | 178.68 Million CAD | 5.87% |
| 2023 FY | 178.68 Million CAD | 20.98% |
| 2023 Q1 | 165.27 Million CAD | 11.9% |
| 2023 Q2 | 157.53 Million CAD | -4.69% |
| 2023 Q3 | 168.77 Million CAD | 7.14% |
| 2022 Q2 | 128.44 Million CAD | 7.28% |
| 2022 Q4 | 147.7 Million CAD | 10.35% |
| 2022 FY | 147.7 Million CAD | 20.28% |
| 2022 Q1 | 119.73 Million CAD | -2.49% |
| 2022 Q3 | 133.85 Million CAD | 4.21% |
| 2021 Q3 | 94.82 Million CAD | 1.75% |
| 2021 FY | 122.79 Million CAD | 26.28% |
| 2021 Q1 | 92.5 Million CAD | -4.87% |
| 2021 Q2 | 93.19 Million CAD | 0.74% |
| 2021 Q4 | 122.79 Million CAD | 29.5% |
| 2020 Q4 | 97.23 Million CAD | 9.71% |
| 2020 FY | 97.23 Million CAD | 31.87% |
| 2020 Q3 | 88.63 Million CAD | 47.87% |
| 2020 Q2 | 59.93 Million CAD | -2.22% |
| 2020 Q1 | 61.3 Million CAD | -16.87% |
| 2019 Q3 | 67.7 Million CAD | 31.24% |
| 2019 FY | 73.73 Million CAD | 571.8% |
| 2019 Q4 | 73.73 Million CAD | 8.91% |
| 2019 Q1 | 48.95 Million CAD | 345.99% |
| 2019 Q2 | 51.59 Million CAD | 5.39% |
| 2018 Q4 | 10.97 Million CAD | 11.36% |
| 2018 FY | 10.97 Million CAD | -24.16% |
| 2018 Q3 | 9.85 Million CAD | 41.84% |
| 2018 Q1 | 12.52 Million CAD | -13.48% |
| 2018 Q2 | 6.94 Million CAD | -44.5% |
| 2017 Q1 | 7.72 Million CAD | 33384.44% |
| 2017 Q2 | 770.33 Thousand CAD | -90.03% |
| 2017 Q3 | 690.88 Thousand CAD | -10.31% |
| 2017 Q4 | 14.47 Million CAD | 1994.8% |
| 2017 FY | 14.47 Million CAD | 62636.31% |
| 2016 FY | 23.06 Thousand CAD | 79.47% |
| 2016 Q4 | 23.06 Thousand CAD | 130.69% |
| 2016 Q2 | 10 Thousand CAD | -22.2% |
| 2016 Q1 | 12.85 Thousand CAD | 0.0% |
| 2016 Q3 | 10 Thousand CAD | 0.0% |
| 2015 Q4 | 12.85 Thousand CAD | 70.25% |
| 2015 Q3 | 7550.00 CAD | 0.0% |
| 2015 FY | 12.85 Thousand CAD | 28.55% |
| 2015 Q2 | 7550.00 CAD | -24.49% |
| 2015 Q1 | 9999.00 CAD | 0.0% |
| 2014 Q4 | 9999.00 CAD | -40.22% |
| 2014 FY | 9999.00 CAD | 0.0% |
| 2014 Q3 | 16.72 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5.38 Million CAD | -3221.286% |
| CanadaBis Capital Inc. | 15.61 Million CAD | -1044.047% |
| Decibel Cannabis Company Inc. | 96.79 Million CAD | -84.612% |
| Delivra Health Brands Inc. | 4.85 Million CAD | -3578.209% |
| Lifeist Wellness Inc. | 9.94 Million CAD | -1697.537% |
| Cannara Biotech Inc. | 61.77 Million CAD | -189.24% |
| Medicure Inc. | 8.16 Million CAD | -2088.992% |
| PharmaCielo Ltd. | 23.96 Million CAD | -645.493% |
| Rubicon Organics Inc. | 16.99 Million CAD | -951.305% |
| BioSyent Inc. | 6.76 Million CAD | -2539.719% |
| Voyageur Pharmaceuticals Ltd. | 727.87 Thousand CAD | -24449.118% |